Receptor inhibition blunts angiotensin II-stimulated nitric oxide release in renal arteries

Journal of the American Society of Nephrology

Volumn 10, Issue 1 SUPPL. 11, 1999, Pages

  Thorup, Christian ^a   Kornfeld, Mark ^b   Goligorsky, Michael S ^c   Moore, Leon C ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BENZIMIDAZOLE DERIVATIVE; NITRIC OXIDE SYNTHASE; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; METABOLISM; MICROELECTRODE; RENAL ARTERY; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; BENZIMIDAZOLES; ENDOTHELIUM, VASCULAR; LOSARTAN; MALE; MICROELECTRODES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENAL ARTERY; TETRAZOLES; VASOCONSTRICTION;

EID: 0032958867     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ohishi K, Carmines PK, Inscho EW, Navar LG: ESRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am J Physiol 263: F900-F906, 1992
2. Sigmon DH, Carretero OA, Beierwaltes WH: Angiotensin dependence of endothelium-mediated renal hemodynamics. Hypertension 20: 643-650, 1992
3. Takenaka T, Mitchell KD, Navar LG: Contribution of angiotensin II to renal hemodynamic and excretory responses to nitric oxide synthesis inhibition in the rat. J Am Soc Nephrol 4: 1046-1053, 1993
4. Ikenaga H, Fallet RW, Carmines PK: Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANG II in rat kidney. Am J Physiol 271: F365-F373, 1996
5. Boulanger CM, Caputo L, Levy BI: Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension 26: 752-757, 1995
6. Gohlke P, Pees C, Unger T: AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 31: 349-355, 1998
7. Hennington BS, Zhang H, Miller MT, Granger JP, Reckelhoff JF: Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension 31: 283-288, 1998
8. Zou AP, Wu F, Cowley AW Jr: Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. Hypertension 31: 271-276, 1998
9. Pueyo ME, Arnal JF, Rami J, Michel JB: Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol 274: C214-C220, 1998
10. Thorup C, Kornfeld M, Winaver JM, Goligorsky MS, Moore LC: Angiotensin II stimulates nitric oxide release in isolated perfused renal resistance arteries. Pflügers Arch 435: 432-434, 1998
11. Casellas D, Moore LC: Autoregulation and tubuloglomerular feedback in juxtamedullary glomerular arterioles. Am J Physiol 258: F660-F669, 1990
12. Casellas D, Navar LG: In vitro perfusion of juxtamedullary nephrons in rats. Am J Physiol 246: F349-F358, 1984
13. Shibouta Y, Inada Y, Ojima M, Wada T, Noda M, Sanada T, Kubo K, Kohara Y, Naka T: Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxyl-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole- 7-carboxylic acid (CV 11974), and its prodrug, ± 1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7- carboxylate (TCV-116). J Pharmacol Exp Ther 266: 114-120, 1993
14. Juncos L A, Ren Y L, Arima S J, Garvin J, Carretero O A, Ito S: Angiotensin II action in isolated microperfused rabbit afferent arterioles is modulated by flow. Kidney Int 49: 374-381, 1996
15. Heinemann A, Wachter CH, Peskar, BA, Hozer P: Dilatation by angiotensin II of the rat femoral arterial bed in vivo via pressure/ flow-induced release of nitric oxide and prostaglandins. Br J Pharmacol 122: 975-984, 1997
16. Pörsti I, Bara AT, Busse R, Hecker M: Corrigendum: Release of nitric oxide by angiotensin (1-7) from porcine coronary endothelium: Implications for a novel angiotensin receptor. Br J Pharmacol 111: 652-654, 1994
17. Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM: Bovine aortic endothelial cells contain an angiotensin (1-7) receptor. Hypertension 29: 388-393, 1997
18. Brosnihan KB, Li P, Ferrario CM: Angiotensin (1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 27: 523-528, 1996